Is there a generic for Metocurine iodide?

The FDA Orange Book does not currently list an approved generic (ANDA) for Metocurine iodide. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Metocurine iodide?

METUBINE IODIDE (NDA 006632, LILLY) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Metocurine iodide are approved?

Metocurine iodide is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Metocurine iodide

Metocurine iodide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:METUBINE IODIDE · NDA 006632

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
METUBINE IODIDE	LILLY	NDA 006632	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Metocurine iodide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo